Author

Øystein Sandanger

PROACTIVE THERAPEUTIC DRUG MONITORING IN THE EARLY PHASE OF INFLIXIMAB THERAPY: RESULTS FROM A 30 WEEK MULTICENTRE RANDOMISED TRIAL OF 400 PATIENTS (THE NOR-DRUM STUDY)
PROACTIVE THERAPEUTIC DRUG MONITORING IN THE EARLY PHASE OF INFLIXIMAB THERAPY: RESULTS FROM A 30 WEEK MULTICENTRE RANDOMISED TRIAL OF 400 PATIENTS (THE NOR-DRUM STUDY)

Øystein Sandanger  et al.

PROACTIVE THERAPEUTIC DRUG MONITORING IS SUPERIOR TO STANDARD TREATMENT DURING MAINTENANCE THERAPY WITH INFLIXIMAB; THE RANDOMIZED NOR-DRUM PART B CLINICAL TRIAL
PROACTIVE THERAPEUTIC DRUG MONITORING IS SUPERIOR TO STANDARD TREATMENT DURING MAINTENANCE THERAPY WITH INFLIXIMAB; THE RANDOMIZED NOR-DRUM PART B CLINICAL TRIAL

Øystein Sandanger  et al.

Item 1 - 2 / 2
1